title: Use of pramipexole to treat amyotrophic lateral sclerosis

abstract: 
The present invention is directed to compositions comprising pramipexole and the use of such compositions to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). As shown in FIG. B the mean +/? SEM serum 2,3-DHBA levels for the 12 ALS participants decreased significantly after pramipexole treatment.